Smart


infection diagnosis Early identifi cation of clinically relevant bacterial infections is crucial to improving patient


outcomes. Furthermore, identifying patients that benefi t from antibiotic treatment and monitoring of antibiotic treatment is recommended for a patient centered therapy. The determination of the infection and sepsis parameter Procalcitonin (PCT) with the immunoassay analyzer Samsung LABGEO IB10


allows now for rapid and reliable decision making 24/7 in acute care settings.


Samsung IB B·R·A·H·M·S PCT at point of care


• For more information visit us at thermoscientifi c.com/brahms


trademarks are the property of Thermo Fisher Scientifi c and its subsidiaries unless otherwise specifi ed. Samsung LABGEO®


is a registered trademark of Samsung C&T Corporation.


Thermo Fisher Scientifi c products are distributed worldwide; not all intended uses and applications mentioned in this printing are registered in every country.


NEW:


PCT testing on Samsung LABGEO IB10


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60